Browse the evidence

Low serum 25-hydroxyvitamin D levels (<50 nmol/L) are strongly associated with frailty in older men, but this association is significantly weaker or non-significant in older women.

If you are an older man, maintaining Vitamin D levels above 50 nmol/L may be critical for preventing frailty, as low levels are strongly linked to it. For women, the link is much weaker, suggesting other factors might be more dominant. Consult a doctor to check your specific levels, as the 'standard' threshold might not apply equally to both sexes.

The blood-glucose and cholesterol-lowering efficacy of oat beta-glucan is determined by the amount and molecular weight of beta-glucan that becomes solubilized in the gastrointestinal tract, which directly dictates the resulting digesta viscosity.

To get blood sugar and cholesterol benefits from oats, choose products where the beta-glucan remains soluble and has a high molecular weight. Processing methods like extensive extrusion, baking into bread, or freeze-thaw cycles can degrade the beta-glucan or reduce its solubility, rendering it ineffective regardless of the total fiber content. Look for minimally processed oats or specific concentrates that maintain viscosity.

Late-afternoon physical performance (strength, power, flexibility) is generally superior to morning performance due to increased core body temperature enhancing peripheral mechanisms like nerve conduction and blood flow.

Schedule your most demanding physical workouts (heavy lifting, sprinting, competitive events) for the late afternoon (4 PM - 8 PM). Your body temperature is higher, which improves nerve conduction, joint flexibility, and blood flow to muscles, leading to better performance and reduced injury risk compared to morning workouts.

Moderate-intensity aerobic exercise training (AET) reverses skeletal muscle atrophy and ubiquitin-proteasome system (UPS) overactivation in heart failure patients by restoring redox balance and normalizing proteasome activity.

If you have heart failure, moderate-intensity aerobic exercise (like brisk walking or uphill walking at 60% of your max capacity) for 50 minutes, twice a week in a supervised setting plus once at home, can reverse muscle wasting and improve your energy levels. This benefit is not achieved by medication alone, so you must include this specific type of exercise in your treatment plan under medical supervision.

Sleep deprivation associated with shift work leads to hormonal changes (reduced leptin, increased ghrelin) that increase appetite and obesity risk.

Ensure you get adequate sleep. If you are sleep-deprived, be aware that your body may signal higher hunger due to hormonal changes. Plan healthy snacks and meals to counteract this biological drive.

Circadian desynchronization caused by shift work contributes to insulin resistance and metabolic syndrome.

Try to maintain a regular sleep-wake cycle as much as possible. Use strategies like bright light exposure during night shifts and dark environments during the day to help synchronize your internal clock.

Oral administration of the growth hormone secretagogue capromorelin to older adults with mild functional limitations significantly increases lean body mass and improves specific measures of physical performance (tandem walk and stair climb) over 6-12 months.

For older adults (65-84) with mild physical limitations, oral capromorelin (a GH secretagogue) taken for 6-12 months can increase lean muscle mass and improve balance and stair-climbing ability. While it causes minor increases in blood sugar and insulin resistance, these were clinically minor in this study. Side effects like increased appetite and insomnia are common but generally tolerable. This is not a substitute for strength training, which was excluded in this study, but offers a pharmacological option for functional decline.

Synthesis of the mitochondrial phospholipid cardiolipin (CL) in brown and beige fat is essential for systemic energy homeostasis, insulin sensitivity, and metabolic flexibility.

Maintaining healthy brown and beige fat function appears crucial for metabolic health. This involves exposure to cold temperatures which naturally upregulates cardiolipin synthesis. While you cannot directly 'dose' cardiolipin, supporting thermogenic capacity through cold exposure may help maintain insulin sensitivity and metabolic flexibility, especially if you have reduced brown fat activity.

Empagliflozin (10 mg/day) significantly reduces liver fibrosis (measured by liver stiffness measurement) in patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease compared to placebo, and reduces liver stiffness more effectively than pioglitazone.

If you have Type 2 Diabetes and fatty liver disease, ask your doctor about empagliflozin (10 mg daily). This study shows it can significantly reduce liver stiffness (a sign of scarring/fibrosis) better than the alternative drug pioglitazone, and better than a placebo. It also helps reduce body weight and visceral fat. Ensure you maintain moderate physical activity and follow dietary advice as part of your treatment.

In patients with type 2 diabetes, the addition of orlistat to a behavioral weight loss intervention yields significantly greater improvements in insulin sensitivity and reductions in plasma free fatty acids (FFA) compared to behavioral intervention alone, despite achieving equivalent total weight loss.

If you have type 2 diabetes and are overweight, adding orlistat (120mg with meals) to a standard weight loss program (diet and exercise) can improve your body's sensitivity to insulin better than diet and exercise alone. This happens because orlistat helps lower free fatty acids in your blood, which directly reduces insulin resistance, even if you lose the same amount of weight as someone not taking the drug.

In middle-aged adults, insomnia and short sleep duration act as mediators linking depression to increased hypertension incidence, suggesting that treating sleep disturbances can reduce cardiovascular risk.

If you are middle-aged and struggling with depression, prioritize treating your sleep problems (insomnia or short sleep duration) as aggressively as you treat your mood. The research indicates that fixing your sleep can significantly lower your risk of developing high blood pressure, which is a major driver of heart disease. This is not just about comfort; it is a cardiovascular protective strategy.

Phase-shifting the circadian clock via controlled light/dark exposure and melatonin reduces circadian misalignment, thereby improving night-shift alertness and performance more effectively than symptomatic countermeasures like caffeine or naps.

To work night shifts safely and healthily, you must reset your body clock, not just mask sleepiness. Use bright light (4000+ lux) for short bursts during your shift, wear dark sunglasses on your commute home to block morning light, and sleep in a pitch-black room. Consider taking melatonin (0.5-3mg) in the morning to help delay your clock. This aligns your biology with your schedule, reducing long-term health risks and improving alertness.

Older women (65-80 years) exhibit a ~30% greater basal muscle protein synthesis (MPS) rate than older men, which likely contributes to slower age-related muscle loss in women.

For older adults, maintaining muscle mass is not just about exercise; biological sex plays a role. Older women naturally have a higher baseline rate of muscle building (MPS) than older men, which helps them lose muscle more slowly. This suggests that nutritional strategies for older men might need to be more aggressive in stimulating MPS to match the natural baseline advantage women have.

Older women exhibit anabolic resistance to feeding, where muscle protein synthesis (MPS) does not increase in response to a protein-containing meal, unlike older men who show a significant increase.

Older women may not get the same muscle-building benefit from a standard meal as older men do. This 'anabolic resistance' means that simply eating protein might not be enough to maintain muscle. Older women might need to focus on higher protein intakes per meal or resistance training to stimulate MPS, as their bodies don't respond to feeding as robustly as men's.

GLP-1 receptor agonists and SGLT2 inhibitors show promising benefits for NAFLD/NASH patients, particularly by addressing underlying metabolic dysfunction, though specific histological resolution data is still emerging.

If lifestyle changes aren't enough to manage your fatty liver, ask your doctor about GLP-1 agonists (like semaglutide) or SGLT2 inhibitors (like empagliflozin). These diabetes/obesity drugs have shown promise in improving liver health by targeting the underlying metabolic issues.

Assessment of metabolic risk factors is critical in patients with NAFLD because advanced liver fibrosis correlates with metabolic comorbidities, and early identification of these factors prevents cardiovascular and liver-related mortality.

If you have NAFLD, focus on managing your metabolic health (blood sugar, blood pressure, weight) even if your liver enzymes look normal. This is the most effective way to protect your heart and liver from serious damage.

Insulin resistance (IR) and hyperinsulinemia are independent, nontraditional risk factors for cardiovascular disease (CVD) in type 2 diabetes, contributing to excess morbidity and mortality beyond traditional risk factors like hypertension and dyslipidemia.

If you have type 2 diabetes or insulin resistance, your risk of heart disease is higher than what standard blood pressure and cholesterol tests show. This is largely driven by how your body handles insulin. Focus on improving insulin sensitivity through lifestyle changes (like weight management and exercise) and medications that address insulin resistance, not just traditional risk factor management.

Inflammation, marked by elevated C-reactive protein (CRP), white blood cells, and adhesion molecules, is a key nontraditional risk factor for CVD in diabetes, linked to insulin resistance and obesity.

Chronic, low-grade inflammation is a major driver of heart disease in diabetes, often stemming from excess body fat and insulin resistance. This inflammation damages blood vessels and promotes clotting. Strategies to reduce body weight and improve insulin sensitivity can lower inflammatory markers like CRP and reduce CVD risk.

Higher percentages of REM and deep sleep are associated with a reduced incidence of atrial fibrillation, while higher light sleep percentages are associated with increased odds of atrial fibrillation.

Prioritize sleep quality that promotes REM and deep sleep. While total duration is important, the composition of your sleep matters for heart health. Consistent sleep schedules and avoiding alcohol before bed may help increase deep and REM sleep, thereby reducing atrial fibrillation risk.

Average daily sleep duration exhibits a J-shaped association with hypertension, major depressive disorder, and generalized anxiety disorder, where both short (5h) and long (10h) durations increase risk compared to the median (6.8h).

Aim for approximately 7 hours of sleep per night. Both sleeping significantly less (5 hours) or significantly more (10 hours) is associated with higher risks of hypertension, depression, and anxiety. Use your wearable to track your average daily sleep duration and adjust your schedule to stay within the moderate range.

GLP-1 receptor agonists (GLP-1RAs) reduce major adverse cardiovascular events (MACE) in type 2 diabetes patients through pleiotropic mechanisms including blood pressure reduction, improved endothelial function, and anti-inflammatory effects, independent of weight loss.

If you have type 2 diabetes and are at risk for heart problems, GLP-1 receptor agonists (like semaglutide or liraglutide) offer heart protection beyond just lowering blood sugar. They work by improving blood vessel function and lowering blood pressure. While they are injections that can cause stomach upset, the cardiovascular benefits are significant and often independent of weight loss.

A low-protein/high-carbohydrate (LPHC) diet or specific restriction of methionine and branched-chain amino acids (BCAAs) extends longevity and improves metabolic health in model organisms and middle-aged humans by suppressing mTORC1 and GH/IGF-1 signaling while promoting autophagy and FGF21 production.

Focus on the source and balance of protein rather than just total grams. Prioritize plant-based proteins and consider reducing methionine-rich animal proteins (like red meat) if you are middle-aged, as this may support longevity pathways. However, ensure adequate protein intake in older age to prevent frailty.

Protracted metformin therapy (1500-2550 mg/day) induces significant weight loss in obese women with PCOS, with higher doses (2550 mg) yielding greater weight reduction in moderately obese patients (BMI 30-37) compared to lower doses.

If you have PCOS and are overweight, metformin can help you lose weight, especially if you take a higher dose (around 2550 mg/day). However, this benefit is most clear if your BMI is between 30 and 37. If you are morbidly obese, higher doses may not give you more weight loss than lower doses. Be prepared for potential stomach issues, which are common.

Testosterone treatment significantly reduces depressive symptoms in men compared to placebo, with efficacy dependent on dosage and baseline symptom homogeneity.

If you are a man experiencing depressive symptoms, testosterone therapy may offer a clinically relevant reduction in symptoms, particularly if your symptoms are consistent (low variability) and you are prescribed a higher dosage (over 500mg/week). This benefit appears regardless of whether you are clinically hypogonadal. Consult a physician to evaluate if this adjunct therapy is appropriate for your specific symptom profile.